Alana Hippensteele, Lead Editor

The results of the study demonstrated that dapagliflozin was able to reduce new-onset diabetes by 32%.

FDA officials based their approval on the review of data and evidence that demonstrated a close similarity between pegfilgrastim-apgf and its reference product.

According to a recent study, patients with type 2 diabetes mellitus (T2D), but not prediabetes, demonstrated poorer cognitive performance 3 to 6 months after a stroke.

A recent study in the UK that estimated the amount of life lost from type 1 and type 2 diabetes in the country’s population found that the loss amounted to approximately 6.4 million years of future life in the current population.

According to a recent study, diet can affect the outcome of chemotherapy due to microbes in the gut that can trigger changes in a patient’s response to drugs.

A recent study was able to identify the region of the brain where executive functioning takes place due to the brain of a unique patient with dys-executive syndrome.

According to a recent study, people with a higher risk of cardiovascular disease demonstrate an increase in cognitive decline, including a rise in the typical markers of Alzheimer disease.

There has been more attention been paid to the pulmonary complications of COVID-19, with less attention being paid to the cardiovascular complications that can result in death or impairment.

According to a recent study, olanzapine may help patients with advanced cancer manage symptoms unrelated to chemotherapy, such as nausea and vomiting.

The US Senate recently passed the Paycheck Protection Program Flexibility Act after its quick success in the House last week.

At the 2020 ASCO Annual Meeting, speaker Leslie R. Ellis, MD, MSHPEd, FACP, discussed the results of studies in a session looking into current research on leukemia, MDS, and allotransplant.

The presence of ongoing SHM or CSR in the context of CLL may support the functionality of DNA damage repair pathways, with potential relevance to therapeutic strategies.

According to a new survey released by the NCPA, COVID-19 is changing how local pharmacies do business across the country, and these changes may be for the long term.

At the 2020 American Society of Clinical Oncology Virtual Scientific Program, researchers presented a recent study that is the largest to date analyzing CLL treatment patterns among VHA patients between 2013 and 2018.

In 2017 alone, there was an estimated 785 fewer cancer deaths in states that adopted Medicaid expansion.

At 5 years follow up, the data showed that the OS for women on olaparib was 42.1%, while the placebo OS was 33.2%.

A new law approved in Minnesota this week expands pharmacists’ authority by allowing them to administer FDA-authorized COVID-19 or SARS-CoV-2 vaccines when they become available.

New York Governor Andrew Cuomo announced last week that New York will launch a COVID-19 testing pilot program with a goal of conducting 7000 tests per week.

A study released today demonstrated that tocilizumab has been shown to significantly improve survival outcomes for patients with COVID-19.

The FDA recently announced its approval of a vaginal gel that acts as a method of contraception for women. It is the first non-hormonal, vaginal pH regulator contraceptive to be approved by the FDA.

The Secretary of HHS, Alex M. Azar II, clarified in a statement that the PREP Act preempts state licensing laws that place restrictions on pharmacists’ ability to order and administer COVID-19 tests.

As states begin to consider reopening businesses around the country, questions remain for pharmacies regarding appropriate strategies to protect the communities they serve from COVID-19.

The anti-cancer medicine venetoclax may improve the current therapy for estrogen receptor-positive (ER+) breast cancer.

To support the successful reopening of the country in a manner that prevents further COVID-19 outbreaks, the NACDS has issued a report in which it urges government action on 3 key objectives.

A harmonized and collaborative approach to coronavirus disease 2019 (COVID-19) vaccine research and development is necessary for a successful outcome.

At the first educational session of PQA, the speakers discussed pharmacists’ roles in influencing outcomes associated with social determinants of health in the US population.

Before COVID-19, the health care industry was largely headed toward a value-based system that was shifting to focus on social determinants of health, according to Bruce Japsen, at the PQA 2020 Annual Meeting.

The authors found that telehealth services were facilitated by patients being able to easily share information with providers from equipment that managed CGM for diabetic ketosis and hyperglycemia.

At the PQA 2020 Annual Meeting on Thursday, speakers discussed some of the drivers of medication adherence in community pharmacy.

A new report from PrEP4All Collaboration warned that current research efforts aimed at controlling the COVID-19 pandemic are missing an important area of research into PrEP.